Carbetocin (Pabal)

Status:: Red
Decision Date:: September 2018

Red Drug Classifications

1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating

Traffic Lights Clinical Guidelines JAPC Other guidelines Further resources